530P Prognostic impact of PIK3CA mutations in patients with endocrine-resistant ER+/HER2- advanced breast cancer: Results from the CHAMBER study.
Saved in:
| Title: | 530P Prognostic impact of PIK3CA mutations in patients with endocrine-resistant ER+/HER2- advanced breast cancer: Results from the CHAMBER study. |
|---|---|
| Authors: | Vernaci, G.M.1 (AUTHOR), Colangelo, C.2 (AUTHOR), Bria, E.3 (AUTHOR), Massa, D.2 (AUTHOR), Giorgi, C.A.1 (AUTHOR), Giarratano, T.1 (AUTHOR), Napetti, D.2 (AUTHOR), Bonomi, G.2 (AUTHOR), Zanghi, F.2 (AUTHOR), Bottosso, M.1 (AUTHOR), Lazzarini, E.1 (AUTHOR), Santarelli, L.1 (AUTHOR), Guarneri, V.2 (AUTHOR), Indraccolo, S.4 (AUTHOR), Dieci, M.V.2 (AUTHOR) |
| Source: | Annals of Oncology. 2025 Supplement 2, Vol. 36, pS425-S425. 1p. |
| Database: | Academic Search Ultimate |
| ISSN: | 09237534 |
|---|---|
| DOI: | 10.1016/j.annonc.2025.08.953 |
